The study, published in The Lancet Oncology journal on Wednesday, analysed 3.9 million cancer cases from New Zealand, Australia, Canada, Denmark, the UK, Ireland and Norway. It compared the one-year and five-year survival rates for bowel, oesophageal, pancreatic, stomach, rectum, lung and ovarian cancer from 1995 to 2014. Read more . . .